ES394860A1 - Procedimiento para la produccion de una vacuna viva contra la bursitis infecciosa de las gallinas. - Google Patents

Procedimiento para la produccion de una vacuna viva contra la bursitis infecciosa de las gallinas.

Info

Publication number
ES394860A1
ES394860A1 ES394860A ES394860A ES394860A1 ES 394860 A1 ES394860 A1 ES 394860A1 ES 394860 A ES394860 A ES 394860A ES 394860 A ES394860 A ES 394860A ES 394860 A1 ES394860 A1 ES 394860A1
Authority
ES
Spain
Prior art keywords
chickens
vaccine against
live vaccine
manufacture
infectious bursitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES394860A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES394860A1 publication Critical patent/ES394860A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES394860A 1970-09-12 1971-09-07 Procedimiento para la produccion de una vacuna viva contra la bursitis infecciosa de las gallinas. Expired ES394860A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2045160A DE2045160C3 (de) 1970-09-12 1970-09-12 Verfahren zur Herstellung einer Lebendvaccine gegen die infektiöse Bursitis der Hühner

Publications (1)

Publication Number Publication Date
ES394860A1 true ES394860A1 (es) 1975-01-01

Family

ID=5782254

Family Applications (1)

Application Number Title Priority Date Filing Date
ES394860A Expired ES394860A1 (es) 1970-09-12 1971-09-07 Procedimiento para la produccion de una vacuna viva contra la bursitis infecciosa de las gallinas.

Country Status (11)

Country Link
US (1) US3769400A (es)
AT (1) AT308967B (es)
BE (1) BE772448A (es)
CH (1) CH560760A5 (es)
DE (1) DE2045160C3 (es)
DK (1) DK129590B (es)
ES (1) ES394860A1 (es)
FR (1) FR2106482B1 (es)
GB (1) GB1327870A (es)
IL (1) IL37682A (es)
NL (1) NL150684B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
WO1985002545A1 (en) * 1983-12-13 1985-06-20 Commonwealth Scientific And Industrial Research Or Infectious bursal disease virus vaccine
HU197846B (en) * 1984-07-02 1989-06-28 Laszlo Csatary Process for producing therapeutic composition suitable for treating virus infections
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines

Also Published As

Publication number Publication date
GB1327870A (en) 1973-08-22
US3769400A (en) 1973-10-30
FR2106482A1 (es) 1972-05-05
DE2045160C3 (de) 1975-04-10
DE2045160A1 (de) 1972-03-30
IL37682A (en) 1974-06-30
AT308967B (de) 1973-07-25
BE772448A (fr) 1972-03-10
IL37682A0 (en) 1971-11-29
DK129590C (es) 1975-03-24
NL150684B (nl) 1976-09-15
CH560760A5 (es) 1975-04-15
DK129590B (da) 1974-10-28
DE2045160B2 (de) 1974-08-22
FR2106482B1 (es) 1974-10-18
NL7112237A (es) 1972-03-14

Similar Documents

Publication Publication Date Title
AT260948B (de) Verfahren zur Herstellung neuer, substituierter Hydroxyhydrocarbyloxyalkylsiloxane
AT247309B (de) Verfahren zur Herstellung neuer, disubstituierter Alkohole
AT258302B (de) Verfahren zur Herstellung neuer 1,2-Dihydro-1,2,4-benztriazine
CH553794A (de) Verfahren zur herstellung neuer bis-(triazinylamino)-stilbene.
AT289796B (de) Verfahren zur Herstellung von neuen, wasserlöslichen Perfluoralkanamidomethylpyridiniumsalzen
ES394860A1 (es) Procedimiento para la produccion de una vacuna viva contra la bursitis infecciosa de las gallinas.
ES293828A1 (es) Método de preparar una vacuna que comprende virus atenuados de panleucopenia
ES258463A1 (es) Un procedimiento de preparar una vacuna trivalente viva contra la poliomelitis
AT265312B (de) Verfahren zur Herstellung neuer, cyclischer Tetraphosphonatverbindungen
NL144277B (nl) Werkwijze ter bereiding van triazineverbindingen met herbicide werking, alsmede werkwijze ter bereiding van herbicide preparaten.
CH451172A (de) Verfahren zur Herstellung neuer substituierter Phenylamino-1,3-diazacyclopentene-(2)
NL145552B (nl) Werkwijze ter bereiding van 3-(5-nitro-2-thiazolyl)-2-oxo-1,3-diazacycloalkaanverbindingen met antiparasitaire werking, werkwijze ter bereiding van farmaceutische perparaten, alsmede de verkregen gevormde preparaten.
CH441347A (de) Verfahren zur Herstellung neuer fluoreszierender 1,2,3-Triazolderivate
ES306989A1 (es) Procedimiento para la produccion de una composicion de vacuna veterinaria.
CH446312A (de) Verfahren zur Herstellung von cis,cis-Cyclodecadien-(1,6)
CH454850A (de) Verfahren zur Herstellung von 1,2-Dichlorpropenpyridinium- resp. Chinoliniumsalzen
DK124340B (da) Fremgangsmåde til fremstilling af stærk svækket, levende Newcastle-syge-virus-vaccine.
CH471136A (de) Verfahren zur Herstellung neuer 1,3-Dihydro-5-aryl-2H-1,4-benzodiazepin-2-on-4-oxyde
BR6349184D0 (pt) Processo para a preparacao de uma vacina viva contra a febre aftosa
CH441304A (de) Verfahren zur Herstellung von 3-Hydroxy- bzw. 3-Alkoxy-, 3-Aralkoxy- oder 3-Cycloalkoxy-1,3,5(10)-östratrienen
CH556334A (de) Verfahren zur herstellung neuer 1,3,3-trisubstituierter 3azolylpropine.
FI41590C (fi) Menetelmä elävän rokotteen valmistamiseksi suu- ja sorkkatautia vastaan
CH433759A (de) Verfahren zur Herstellung neuer Copolymere
CH441354A (de) Verfahren zur Herstellung neuer Derivate von 6-Methyl- und 1,6-Dimenthyl-ergolin I
CH451195A (de) Verfahren zur Herstellung von 2-Chlor-4H-1,3,2-dioxaphosphorin-4-one